Best Known For
bupropion XL, a medication used to treat depression and seasonal affective disorder
Core Claims
- U.S. patent for bupropion XL is set to expire in 2026
- Generic versions are expected to decrease overall medication cost
- Generic bupropion XL requires FDA approval and bioequivalence
Differentiators
- Extended-release (XL) formulation is designed to release over a 24-hour period
- XL is once-daily dosing
Pricing Perception:
Mid Range